Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001593968-24-000197

Chief Technical Officer acquired 96,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MOORE TIMOTHY L. · Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-25 Grant or award : show line 1 in the form +96,600 282,819 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-25 Grant or award : show line 2 in the form Stock Option (Right to buy) +341,515 341,515 D
Loading xslF345X05/primary_01.xml…